Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Unsubscribe from this list.
  Pharmaceutical Technology Europe E-Alert
 
October 16, 2009
IN THIS ISSUE
Pharma’s bright future
Drug solubility initiative
Cancer drug spend
SAFC facility
More...

IMS raises global pharma market growth forecast
IMS Health delivered some good news last week with its updated pharmaceutical market forecast. More...

Drug solubility initiative launched at CPhI
ISP Pharmaceuticals is embarking on a Drug Solubility Initiative to support pharma companies working with poorly soluble drug actives. More...

Cancer drugs account for 5% of overall drug spending
For the first time, cancer treatments accounted for 5% of overall drug spending in the first half of 2009, according to Medco Health Solutions. More...

SAFC announces $12-million expansion to Carlsbad facility
SAFC Pharma has completed a $12-million expansion to its contract manufacturing facility in Carlsbad (CA, USA), which will expand the company’s services for its later phase and commercial clients. More...

Join PTE on LinkedIn!
Join Pharmaceutical Technology Europe's group on LinkedIn. More...

Key Topic Updates
October events
L.A.B. Exhibition and Conference (27–29 October | UK)
GPhA/FDA Fall Technical Conference (27–29 October | USA)
World Conference on Regenerative Medicine 2009 (29–31 October | Germany)
More events
 
Latest blog posts
Understanding QbD requires basic fundamentals
Free webcast: complex documents in the pharmaceutical industry made easy
Stem cells get a big boost from a small molecule
More blog posts
 
Latest peer-reviewed research
Formulation and evaluation of Famotidine floating matrix tablets
Verification methods for 198 common raw materials using a handheld raman spectrometer
Removing endotoxin from biopharmaceutical solutions
More peer-reviewed research

Key Topic Updates

Survey
How would you characterize the current market for contract manufacturing for small-molecules?
  Poor 9%
  Flat 22%
  Fair 34%
  Moderate 19%
  Strong 16%

This week we would like to know...

Is FDA's initiative to better inform the public of what it does the right step for the agency?
Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, please contact us by emailing magazines@superfill.comor by mail at Advanstar Communications, Advanstar House, Park West, Sealand Road, Chester, CH1 4RN, UK.